{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:29:53Z","timestamp":1776742193630,"version":"3.51.2"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.kint.2023.09.024","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T04:20:16Z","timestamp":1698553216000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploiting the neonatal crystallizable fragment receptor to treat kidney disease"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-8605","authenticated-orcid":false,"given":"James F.","family":"Dylewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Blaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.09.024_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(66)92190-8","article-title":"The transmission of immunity from mother to young and the catabolism of immunoglobulins","volume":"2","author":"Brambell","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.09.024_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/337184a0","article-title":"An Fc receptor structurally related to MHC class I antigens","volume":"337","author":"Simister","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.kint.2023.09.024_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2370.2000.00225.x","article-title":"Cloning and analysis of the gene encoding the human neonatal Fc receptor","volume":"27","author":"Mikulska","year":"2000","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.kint.2023.09.024_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.kint.2023.09.024_bib5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/372336a0","article-title":"Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.kint.2023.09.024_bib6","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00084a037","article-title":"The class I major histocompatibility complex related Fc receptor shows pH-dependent stability differences correlating with immunoglobulin binding and release","volume":"32","author":"Raghavan","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.kint.2023.09.024_bib7","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1074\/jbc.M006684200","article-title":"Tryptophan- and dileucine-based endocytosis signals in the neonatal Fc receptor","volume":"276","author":"Wu","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2023.09.024_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cei.12002","article-title":"Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor","volume":"171","author":"Gouilleux-Gruart","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2567.2006.02408.x","article-title":"A\u00a0variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter","volume":"119","author":"Sachs","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2023.09.024_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygeno.2017.04.006","article-title":"Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer","volume":"109","author":"O'Shannessy","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.kint.2023.09.024_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1242\/jcs.116327","article-title":"Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway","volume":"126","author":"Gan","year":"2013","journal-title":"J\u00a0Cell Sci"},{"issue":"suppl 1","key":"10.1016\/j.kint.2023.09.024_bib13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s10875-012-9768-y","article-title":"The immunologic functions of the neonatal Fc receptor for IgG","volume":"33","author":"Rath","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.V114632","article-title":"Characterization and localization of the neonatal Fc receptor in adult human kidney","volume":"11","author":"Haymann","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2008090976","article-title":"Renal FcRn reclaims albumin but facilitates elimination of IgG","volume":"20","author":"Sarav","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib17","series-title":"KPMP datasets for \"an atlas of healthy and injured cell states and niches in the human kidney\"","year":"2022"},{"key":"10.1016\/j.kint.2023.09.024_bib18","doi-asserted-by":"crossref","first-page":"F358","DOI":"10.1152\/ajprenal.0164.2001","article-title":"FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells","volume":"282","author":"Kobayashi","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2023.09.024_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209732","article-title":"Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Dylewski","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.09.024_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.39499","article-title":"Lupus nephritis IgG induction of calcium\/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function","volume":"68","author":"Ichinose","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2023.09.024_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.stem.2018.10.010","article-title":"Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics","volume":"23","author":"Wu","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.kint.2023.09.024_bib22","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.kint.2023.09.024_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1083\/jcb.71.2.666","article-title":"pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat","volume":"71","author":"Rodewald","year":"1976","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.kint.2023.09.024_bib24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.158.5.2211","article-title":"Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1","volume":"158","author":"Medesan","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 A of an FcRn\/heterodimeric Fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.kint.2023.09.024_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/eji.1830240308","article-title":"Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis","volume":"24","author":"Kim","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/intimm\/dxg018","article-title":"Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans","volume":"15","author":"Ward","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.09.024_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.200809122","article-title":"The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity","volume":"185","author":"Tzaban","year":"2009","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.kint.2023.09.024_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1091\/mbc.e07-07-0658","article-title":"Ca2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway","volume":"19","author":"Dickinson","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.kint.2023.09.024_bib31","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.1408766112","article-title":"Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics","volume":"112","author":"Schoch","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib32","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/dmd.111.039453","article-title":"Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.kint.2023.09.024_bib33","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.170.7.3528","article-title":"The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs","volume":"170","author":"Roopenian","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib34","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.179.7.4580","article-title":"Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism","volume":"179","author":"Akilesh","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib35","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.0810796106","article-title":"Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice","volume":"106","author":"Montoyo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib36","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1172\/JCI114947","article-title":"Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin","volume":"86","author":"Waldmann","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.09.024_bib37","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1073\/pnas.0402970101","article-title":"Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level","volume":"101","author":"Ober","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib38","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1091\/mbc.e04-08-0735","article-title":"From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling","volume":"16","author":"Ward","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.kint.2023.09.024_bib39","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","article-title":"Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn1","volume":"172","author":"Ober","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2023.09.024_bib41","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/bi052628y","article-title":"Albumin binding to FcRn: distinct from the FcRn-IgG interaction","volume":"45","author":"Chaudhury","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.kint.2023.09.024_bib42","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1074\/jbc.M117.794248","article-title":"Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin","volume":"292","author":"Schmidt","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2023.09.024_bib43","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1091\/mbc.e13-04-0174","article-title":"Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules","volume":"24","author":"Weflen","year":"2013","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.kint.2023.09.024_bib44","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.0801717105","article-title":"Dependence of antibody-mediated presentation of antigen on FcRn","volume":"105","author":"Qiao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib45","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1073\/pnas.1019037108","article-title":"Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells","volume":"108","author":"Baker","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2023.09.024_bib46","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1172\/JCI27821","article-title":"Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria","volume":"116","author":"Yoshida","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.09.024_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00274-21","article-title":"The murine neonatal Fc receptor is required for transport of immunization-induced C.\u00a0difficile-specific IgG to the gut and protection against disease but does not affect disease susceptibility","volume":"89","author":"Amadou Amani","year":"2021","journal-title":"Infect Immun"},{"key":"10.1016\/j.kint.2023.09.024_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/intimm\/dxh380","article-title":"The MHC class I-related FcRn ameliorates murine Lyme arthritis","volume":"18","author":"Crowley","year":"2006","journal-title":"Int Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284636","article-title":"Knockout of the neonatal Fc receptor alters immune complex trafficking and lysosomal function in cultured podocytes","volume":"18","author":"Haddad","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.09.024_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230401","article-title":"Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis","volume":"15","author":"Dylewski","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.09.024_bib51","first-page":"F601","article-title":"Intrarenal handling of proteins in rats using fractional micropuncture technique","volume":"263","author":"Tojo","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2023.09.024_bib52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ki.5002041","article-title":"The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states","volume":"71","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.09.024_bib53","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1152\/physrev.00014.2021","article-title":"Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications","volume":"102","author":"Molitoris","year":"2022","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2023.09.024_bib54","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1681\/ASN.2013010018","article-title":"Albumin is recycled from the primary urine by tubular transcytosis","volume":"24","author":"Tenten","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)\u2013Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.024_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.kint.2023.09.024_bib57","first-page":"682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: a next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.kint.2023.09.024_bib59","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","article-title":"Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2023.09.024_bib60","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1200\/JCO.2008.18.5397","article-title":"Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer","volume":"27","author":"Gradishar","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2023.09.024_bib61","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1158\/0008-5472.CAN-17-0604","article-title":"Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy","volume":"77","author":"Chatterjee","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2023.09.024_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1040-8428(97)00015-2","article-title":"Plasma protein (albumin) catabolism by the tumor itself\u2014implications for tumor metabolism and the genesis of cachexia","volume":"26","author":"Stehle","year":"1997","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.kint.2023.09.024_bib63","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.immuni.2013.11.003","article-title":"Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer","volume":"39","author":"Baker","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2023.09.024_bib64","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.18632\/oncotarget.13869","article-title":"Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption","volume":"8","author":"Swiercz","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2023.09.024_bib65","first-page":"2708","article-title":"Fc receptor expression as a prognostic factor in patients with non-small-cell lung cancer","volume":"36","author":"Kim","year":"2022","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.kint.2023.09.024_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114237","article-title":"Deciphering albumin-directed drug delivery by imaging","volume":"185","author":"Hu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.kint.2023.09.024_bib67","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.4049\/jimmunol.0804182","article-title":"Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates","volume":"182","author":"Yeung","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/dmd.109.031310","article-title":"Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys","volume":"38","author":"Deng","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.kint.2023.09.024_bib69","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.4049\/jimmunol.1401218","article-title":"Fc engineering of human IgG1 for altered binding to the neonatal Fc receptor affects Fc effector functions","volume":"194","author":"Grevys","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib70","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.1003584","article-title":"The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells","volume":"186","author":"Liu","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728322","article-title":"The dual targeting of FcRn and Fc\u03b3Rs via monomeric Fc fragments results in strong inhibition of IgG-dependent autoimmune pathologies","volume":"12","author":"Monnet","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib72","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.kint.2023.09.024_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195909","article-title":"Design and preclinical characterization of ALXN1210: a novel anti-C5 antibody with extended duration of action","volume":"13","author":"Sheridan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.09.024_bib74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bjh.16711","article-title":"Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies","volume":"191","author":"Peffault de Latour","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2023.09.024_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.863095","article-title":"FcRn antagonism leads to a decrease of desmoglein-specific B cells: secondary analysis of a phase 2 study of efgartigimod in pemphigus vulgaris and pemphigus foliaceus","volume":"13","author":"Maho-Vaillant","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib87","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40265-022-01678-3","article-title":"Efgartigimod: first approval","volume":"82","author":"Heo","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.kint.2023.09.024_bib93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(23)00077-7","article-title":"Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study","volume":"22","author":"Bril","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.kint.2023.09.024_bib107","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.kint.2023.09.024_bib108","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cpt.1276","article-title":"M281, an anti-FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first-in-human study","volume":"105","author":"Ling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.kint.2023.09.024_bib109","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/cts.13019","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers","volume":"14","author":"Yap","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.kint.2023.09.024_bib110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/d41591-023-00024-8","article-title":"Janssen's nipocalimab tackles hemolytic disease of the fetus and newborn","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2023.09.024_bib111","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","article-title":"Lysosomes as a therapeutic target","volume":"18","author":"Bonam","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.kint.2023.09.024_bib112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","article-title":"The ERK cascade: distinct functions within various subcellular organelles","volume":"2","author":"Wortzel","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.kint.2023.09.024_bib113","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaci.2020.07.016","article-title":"Targeting FcRn for immunomodulation: benefits, risks, and practical considerations","volume":"146","author":"Peter","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib114","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40120-022-00345-9","article-title":"Therapeutic effects of batoclimab in Chinese patients with generalized myasthenia gravis: a double-blinded, randomized, placebo-controlled phase II study","volume":"11","author":"Yan","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.kint.2023.09.024_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.892534","article-title":"Clinical significance of serum albumin and implications of FcRn inhibitor treatment in IgG-mediated autoimmune disorders","volume":"13","author":"Ward","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib116","article-title":"Quantitation of apoptosis and necrosis by annexin V binding, propidium iodide uptake, and flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.kint.2023.09.024_bib117","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tibs.2020.09.004","article-title":"How lysosomes sense, integrate, and cope with stress","volume":"46","author":"Saftig","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.kint.2023.09.024_bib118","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1172\/JCI99507","article-title":"CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease","volume":"128","author":"Maeda","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2023.09.024_bib119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/BOR.0000000000000578","article-title":"The immune podocyte","volume":"31","author":"Bhargava","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2023.09.024_bib120","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3389\/fimmu.2018.02113","article-title":"Calcium\/calmodulin kinase IV controls the function of both T cells and kidney resident cells","volume":"9","author":"Ferretti","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.09.024_bib121","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2009080805","article-title":"Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis","volume":"21","author":"Yung","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib122","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.090194","article-title":"Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus","volume":"37","author":"Cash","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2023.09.024_bib123","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2006.02433.x","article-title":"Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus","volume":"119","author":"Liang","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2023.09.024_bib124","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/art.39722","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis","volume":"68","author":"Rovin","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2023.09.024_bib125","doi-asserted-by":"crossref","first-page":"C1048","DOI":"10.1152\/ajpcell.00235.2019","article-title":"Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton","volume":"317","author":"Tonsawan","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2023.09.024_bib126","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal Fc receptor promotes immune complex-mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib127","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.09.024_bib128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.024_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109474","article-title":"Targeted inhibition of FcRn reduces NET formation to ameliorate experimental ulcerative colitis by accelerating ANCA clearance","volume":"113","author":"Wen","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.kint.2023.09.024_bib130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2023.09.024_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660900","article-title":"Measuring the impact of targeting FcRn-mediated IgG recycling on donor-specific alloantibodies in a sensitized NHP model","volume":"12","author":"Manook","year":"2021","journal-title":"Front Immunol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823007470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823007470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:47:39Z","timestamp":1728881259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823007470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0085253823007470"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.024","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting the neonatal crystallizable fragment receptor to treat kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}